A non-randomized comparative study using different doses of acyclovir to prevent Herpes Simplex reactivation in patients submitted to autologous stem cell transplantation

Brazilian Journal of Infectious Diseases

Volumn 9, Issue 4, 2005, Pages 330-335

  Atalla, Angelo ^a   Maiolino, Angelo ^b   Guimarães, Maria Angélica ^b   Guimarães, Antonio Carlos ^b   Nucci, Marcio ^b  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Acyclovir; Prophylaxis; Stem cell transplantation

Indexed keywords

ACICLOVIR; AMIKACIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CARMUSTINE; CEFEPIME; CEFTAZIDIME; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG DOSE REGIMEN; FEMALE; FEVER; HEALTH CARE COST; HEMATOLOGIC DISEASE; HERPES SIMPLEX; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; ORAL BIOPSY; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RANDOMIZATION; SCHOOL CHILD; SIDE EFFECT; VIRUS CULTURE; VIRUS EXCRETION; VIRUS INHIBITION; VIRUS REACTIVATION;

EID: 31344460077     PISSN: 14138670     EISSN: 14138670     Source Type: Journal    
DOI: 10.1590/S1413-86702005000400010     Document Type: Article

References (16)

1. Saral R., Burns W.H., Prentice H.G. Herpes virus infections: Clinical manifestations and therapeutic strategies in immunocompromised patients. Clin Haematol 1984;13:645-60.
2. Hann I.M., Prentice H.G., Blacklock H.A., et al. Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. Br Med J (Clin Res Ed) 1983;287:384-8.
3. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2000;6:659-713.
4. Saral R., Burns W.H., Laskin O.L., et al. Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med 1981;305:63-7.
5. Gluckman E., Lotsberg J., Devergie A., et al. Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir. Lancet 1983;2:706-8.
6. Wade J.C., Newton B., Flournoy N., Meyers J.D. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. Ann Intern Med 1984;100:823-8.
7. Angelopulos C., Gore S., Braine H.G., et al. Successful intravenous acyclovir (ACV) prophylaxis against Herpes Simples; Virus (HSV) infection/reativation during Intensive chemotherapy of leukemia: 1000 courses (abstract H-143, page 205). Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1995.
8. Arvin A.M., Prober C.G. Herpes Simples viruses. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. Washington, D.C.: American Society for Microbiology Press, 1995;876-83.
9. Zirn J.R., Tompkins S.D., Huie C., Shea C.R. Rapid detection and distinction of cutaneous herpes virus infections by direct immunofluorescence. J Am Acad Dermatol 1995;33:724-8.
10. Nucci M., Landau M., Silveira F., et al. Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides. Infect Control Hosp Epidemiol 2001;22:651-3.
11. Hughes W.T., Armstrong D., Bodey G.P., et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis 1907;25:551-73.
12. Miller A.B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
13. Beyer J., Schwella N., Zingsem J., et al. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: A randomized comparison. J Clin Oncol 1995; 13:1328-35.
14. Baglin T.P., Gray J.J., Marcus R.E., Wreghitt T.G. Antibiotic resistant fever associated with herpes simplex virus infection in neutropenic patients with haematological malignancy. J Clin Pathol 1989;42:1255-8.
15. Lonnqvist B., Palmblad J., Ljungman P., et al. Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden. Support Care Cancer 1993; 1:139-44.
16. Cordonnier C., Buzyn A., Leverger G., et al. Epidemiology and risk factors for Gram-positive coccal infections in neutropenia: Toward a more targeted antibiotic strategy. Clin Infect Dis 2003;36:149-58.